UFMylation at the Crossroads of Health and Cancer: A Blessing in Disguise
The FASEB Journal · 2026
DOI: 10.1096/fj.202501039r ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2026. Verfasst von Congcong Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Life Sciences, Northwest University, Xi'an, China. Hauptthemen laut MEDLINE: Neoplasms, Protein Processing, Post-Translational, Ubiquitination, Ubiquitin. Die Arbeit nennt 104 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Fund for Scientific and Technological Innovation Team of Shaanxi Innovation Capability Support Plan, Scientific and Technological Innovation Team of Shaanxi Innovation Capability Support Plan.
Abstract (Originalsprache)
Despite its similarity in structural basis with ubiquitin system, UFMylation, an emerging ubiquitin‐like (UBL) posttranslational modification, is characterized by covalent conjugation of Ubiquitin‐fold modifier 1 (UFM1) to the target proteins, which can regulate diverse cellular processes to maintain cellular homeostasis. Growing evidence has revealed that UFMylation is associated with developmental disorders, tumorigenesis, heart failure and inflammation. Here, we highlight a comprehensive advance in the components and the biochemical peculiarities of UFMylation system, as well as its pathophysiological roles in cancer. Then the potential of chemicals targeting UFMylation for cancer therapy is discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Life Sciences, Northwest University, Xi'an, China.
- State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers and National Clinical Research Center for Digestive Diseases, Department of Biochemistry and Molecular Biology, Fourth Military Medical…
- Department of Thoracic Surgery, Tangdu Hospital, Second Affiliated Hospital of the Air Force Medical University, Xi'an, China.
- School of Life Sciences and Technology, Yan'an University, Yan'an, China.
ORCID-Profile: Congcong Li
Förderung
- National Natural Science Foundation of China
- Fund for Scientific and Technological Innovation Team of Shaanxi Innovation Capability Support Plan
- Scientific and Technological Innovation Team of Shaanxi Innovation Capability Support Plan
Zitieren
APA
Li, C., Zhong, D., Ma, Y., Sun, R., Chen, J., Wang, Q., Jia, L., Li, X., & Ru, Y. (2026). UFMylation at the Crossroads of Health and Cancer: A Blessing in Disguise. The FASEB Journal. https://doi.org/10.1096/fj.202501039r
Vancouver
Li C, Zhong D, Ma Y, Sun R, Chen J, Wang Q, et al. UFMylation at the Crossroads of Health and Cancer: A Blessing in Disguise. The FASEB Journal. 2026. doi:10.1096/fj.202501039r
BibTeX
@article{Li2026,
author = {Li, Congcong and Zhong, Daixing and Ma, Yuqian and Sun, Ruiqi and Chen, Jia and Wang, Qinhao and Jia, Lintao and Li, Xia and Ru, Yi},
title = {UFMylation at the Crossroads of Health and Cancer: A Blessing in Disguise},
journal = {The FASEB Journal},
year = {2026},
doi = {10.1096/fj.202501039r}
}
EUVIMED